Bone Biologics Corporatio...

NASDAQ: BBLG · Real-Time Price · USD
2.33
-0.02 (-0.85%)
At close: Aug 14, 2025, 3:59 PM
2.35
0.86%
Pre-market: Aug 15, 2025, 05:49 AM EDT

Bone Biologics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-4.22M -9.43M -3.67M -1.1M
Interest Income
55.66K 1.87K 731.71 805.11
Pretax Income
-7.33M -8.95M -1.49M -1.61M
Net Income
-4.11M -8.95M -1.49M -1.61M
Selling & General & Admin
2.09M 2.52M 2.09M 1.02M
Research & Development
2.13M 6.91M 1.58M 82.04K
Other Expenses
n/a n/a n/a -44
Operating Expenses
4.22M 9.43M 3.67M 1.1M
Interest Expense
n/a n/a 731.71K 805.11K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4.22M 9.43M 3.67M 1.1M
Income Tax Expense
n/a n/a n/a 1.6K
Shares Outstanding (Basic)
1.52M 263.14K 47.6K 43K
Shares Outstanding (Diluted)
1.52M 263.14K 47.66K 43.13K
EPS (Basic)
-4.83 -34.01 -31.15 -37.35
EPS (Diluted)
-4.83 -34.01 -31.2 -37.35
EBITDA
-4.11M 479.57K -4.4M -1.1M
EBIT
-4.11M -8.95M -3.67M -805.58K
Depreciation & Amortization
n/a 9.43M 3.67M 1.1M